NASDAQ:EXAS
EXACT Sciences Corporation Stock News
$50.38
-1.57 (-3.02%)
At Close: May 17, 2024
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
10:35pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
Exact Sciences (EXAS) delivered earnings and revenue surprises of 20% and 6.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
After-Hours Action: What's Going On With Exact Sciences Stock?
10:17pm, Tuesday, 21'st Feb 2023 Benzinga
Exact Sciences Corp (NASDAQ: EXAS) shares are facing selling pressure after the close on Tuesday on the heels of the company's quarterly results.
What Happened: Exact Sciences said fourth-quarter
Exact Sciences Corporation (EXAS) Q4 2022 Earnings Call Transcript
09:07pm, Tuesday, 21'st Feb 2023
Exact Sciences Corporation (NASDAQ:EXAS ) Q4 2022 Earnings Conference Call February 21, 2023 5:00 PM ET Company Participants Megan Jones - Investor Relations Kevin Conroy - Chairman and Chief Executiv
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Tuesday, 21'st Feb 2023
Exact Sciences (EXAS) delivered earnings and revenue surprises of 20% and 6.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
01:06pm, Monday, 20'th Feb 2023 Zacks Investment Research
High labor costs, along with inflationary pressures, are likely to have weighed on DaVita's (DVA) fourth-quarter top line.
5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
12:11pm, Monday, 20'th Feb 2023 Zacks Investment Research
The following five large-cap stocks are set to beat Q4 earnings estimates this week. These are: TECK, LECO, NI, EXAS and GFL.
5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
08:17am, Monday, 20'th Feb 2023
The following five large-cap stocks are set to beat Q4 earnings estimates this week. These are: TECK, LECO, NI, EXAS and GFL.
Cathie Wood Bulks Up On Shopify Amid Stock's 18% Post-Earnings Drop, Sells This Major Holding Up 30% This Week
02:35pm, Saturday, 18'th Feb 2023 Benzinga
Cathie Wood’s Ark Invest reversed its stance on Canadian e-commerce retailer Shopify, Inc. (NYSE: SHOP) and began bulking up on the stock this week.
Shopping For Shopify: Ark Invest, through its f
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
01:50pm, Friday, 17'th Feb 2023 Zacks Investment Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Friday, 17'th Feb 2023
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?
04:00pm, Thursday, 16'th Feb 2023 The Motley Fool
Which of these rebounding biotech stocks is the better buy right now?
Why Earnings Season Could Be Great for Exact Sciences (EXAS)
01:36pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?
11:00am, Thursday, 16'th Feb 2023
Which of these rebounding biotech stocks is the better buy right now?
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
03:00pm, Wednesday, 15'th Feb 2023 Zacks Investment Research
Allogene Therapeutics (ALLO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exact Sciences Corporation: Fully Priced After Big Rally
12:22pm, Wednesday, 15'th Feb 2023
Today, we zero in on Exact Sciences Corporation, best known for its "best of breed" non-invasive stool-based DNA screening test called Cologuard. Exact Sciences stock has soared 35% so far in 2023 tha
